TrialJournal of the European Academy of Dermatology and Venereology : JEADV2017

Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria.

A Y Finlay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.